133 related articles for article (PubMed ID: 20166179)
1. Evaluation of the performance of the novel PapilloCheck HPV genotyping test by comparison with two other genotyping systems and the HC2 test.
Schopp B; Holz B; Zago M; Stubenrauch F; Petry KU; Kjaer SK; Iftner T
J Med Virol; 2010 Apr; 82(4):605-15. PubMed ID: 20166179
[TBL] [Abstract][Full Text] [Related]
2. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the PapilloCheck DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set.
Jones J; Powell NG; Tristram A; Fiander AN; Hibbitts S
J Clin Virol; 2009 Jun; 45(2):100-4. PubMed ID: 19394266
[TBL] [Abstract][Full Text] [Related]
4. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types.
Klug SJ; Molijn A; Schopp B; Holz B; Iftner A; Quint W; J F Snijders P; Petry KU; Krüger Kjaer S; Munk C; Iftner T
J Med Virol; 2008 Jul; 80(7):1264-74. PubMed ID: 18461626
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the PapilloCheck® assay with the digene HC2 HPV DNA assay for the detection of 13 high-risk human papillomaviruses in cervical and anal scrapes.
Didelot MN; Boulle N; Damay A; Costes V; Segondy M
J Med Virol; 2011 Aug; 83(8):1377-82. PubMed ID: 21678441
[TBL] [Abstract][Full Text] [Related]
7. Comparison of INNO-LiPA genotyping extra and hybrid capture 2 assays for detection of carcinogenic human papillomavirus genotypes.
Barzon L; Militello V; Pagni S; Palù G
J Clin Virol; 2012 Nov; 55(3):256-61. PubMed ID: 22877561
[TBL] [Abstract][Full Text] [Related]
8. Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping.
Seme K; Fujs K; Kocjan BJ; Poljak M
J Virol Methods; 2006 Jun; 134(1-2):252-6. PubMed ID: 16417931
[TBL] [Abstract][Full Text] [Related]
9. The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform.
Eder PS; Lou J; Huff J; Macioszek J
J Clin Virol; 2009 Jul; 45 Suppl 1():S85-92. PubMed ID: 19651374
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the f-HPV typing™ and Hybrid Capture II® assays for detection of high-risk HPV genotypes in cervical samples.
Cañadas MP; Cirigliano V; Darwich L; Sirera G; Coll J; Clotet B; Videla S
J Virol Methods; 2012 Jul; 183(1):14-8. PubMed ID: 22449759
[TBL] [Abstract][Full Text] [Related]
11. Detection and genotyping of human papillomavirus by real-time PCR assay.
Moreau F; Fetouchi R; Micalessi I; Brejeon V; Bacon N; Jannes G; Le Pendeven C; Lekbaby B; Kremsdorf D; Lacau Saint Guily J; Soussan P
J Clin Virol; 2013 Mar; 56(3):244-9. PubMed ID: 23182775
[TBL] [Abstract][Full Text] [Related]
12. Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA.
Perrons C; Jelley R; Kleter B; Quint W; Brink N
J Clin Virol; 2005 Apr; 32(4):278-85. PubMed ID: 15780805
[TBL] [Abstract][Full Text] [Related]
13. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR.
Lin CY; Chao A; Yang YC; Chou HH; Ho CM; Lin RW; Chang TC; Chiou JY; Chao FY; Wang KL; Chien TY; Hsueh S; Huang CC; Chen CJ; Lai CH
J Clin Virol; 2008 Aug; 42(4):361-7. PubMed ID: 18455959
[TBL] [Abstract][Full Text] [Related]
15. Comparison of HPV sign genotyping test with INNO-LiPA HPV genotyping extra assay on histologic and cytologic cervical specimens.
Barbieri D; Nocera M; Gallinella G; Gentilomi GA; Plazzi M; Costa S; Santini D; Venturoli S
Diagn Microbiol Infect Dis; 2012 Sep; 74(1):43-8. PubMed ID: 22717156
[TBL] [Abstract][Full Text] [Related]
16. High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping.
Tanzi E; Bianchi S; Fasolo MM; Frati ER; Mazza F; Martinelli M; Colzani D; Beretta R; Zappa A; Orlando G
J Med Virol; 2013 Jan; 85(1):91-8. PubMed ID: 23097252
[TBL] [Abstract][Full Text] [Related]
17. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.
Perrons C; Kleter B; Jelley R; Jalal H; Quint W; Tedder R
J Med Virol; 2002 Jun; 67(2):246-52. PubMed ID: 11992586
[TBL] [Abstract][Full Text] [Related]
18. Comparison of SPF10 real-time PCR and conventional PCR in combination with the INNO-LiPA HPV Genotyping Extra assay for the detection and typing of human papillomavirus in cervical samples.
Micalessi MI; Boulet GA; Pillet S; Jacquet J; Pozzetto B; Bogers JJ; Bourlet T
J Virol Methods; 2013 Dec; 194(1-2):113-7. PubMed ID: 23978605
[TBL] [Abstract][Full Text] [Related]
19. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
Castle PE; Schiffman M; Burk RD; Wacholder S; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1394-9. PubMed ID: 12433717
[TBL] [Abstract][Full Text] [Related]
20. Comparison between the Hybrid Capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia.
Gustavsson I; Juko-Pecirep I; Backlund I; Wilander E; Gyllensten U
J Clin Virol; 2009 Jun; 45(2):85-9. PubMed ID: 19451022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
